In vitro testing in tumor immunotherapy.
D000912:Antibodies, Neoplasm; D000936:Antigen-Antibody Complex; D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum; D001402:B-Lymphocytes / Q000276:immunology; D002272:Carcinoembryonic Antigen; D002455:Cell Division; D002464:Cell Migration Inhibition; D002999:Clone Cells / Q000276:immunology; D003601:Cytotoxicity Tests, Immunologic; D005455:Fluorescent Antibody Technique; D006801:Humans; D007109:Immunity; D007111:Immunity, Cellular; D007167:Immunotherapy; D066298:In Vitro Techniques; D008213:Lymphocyte Activation; D008264:Macrophages / Q000276:immunology; D009369:Neoplasms / Q000175:diagnosis / Q000276:immunology / Q000628:therapy*; D011379:Prognosis; D011863:Radioimmunoassay; D013601:T-Lymphocytes / Q000276:immunology; D000509:alpha-Fetoproteins
D000912:Antibodies, Neoplasm; D000936:Antigen-Antibody Complex; D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum; D002272:Carcinoembryonic Antigen; D000509:alpha-Fetoproteins